Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

Nature Medicine

Volumn 2, Issue 1, 1996, Pages 52-58

  Hsu, Frank J ^a   Benike, Claudia ^b   Fagnoni, Francesco ^b   Liles, Tina Marie ^a   Czerwinski, Debra ^a   Taidi, Behnaz ^a   Engleman, Edgar G ^b   Levy, Ronald ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; KEYHOLE LIMPET HEMOCYANIN;

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ADULT; ANTIGEN-PRESENTING CELLS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; HUMANS; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; PILOT PROJECTS; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANTATION, AUTOLOGOUS; VACCINATION;

EID: 0030026776     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0196-52     Document Type: Article

References (10)

1. Lynch, R.G. et al. Immunoregulation of murine myeloma cell growth and differentiation: A monoclonal model of B cell differentiation. Immunol. Rev. 48, 45-80 (1979).
2. Levy, R., Hatzubia, A., Brown, S., Maloney, D. & Dilley, J. Immunoglobulin idiotype: A tumor-specific antigen for human B-cell lymphomas. in Malignant Lymphomas, ch. 5 (Academic Press, New York, 1982).
3. Maloney, D.G., Kaminski, M.S., Burowski, D., Haimovich, J. & Levy, R. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: Characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4, 191-209 (1985).
4. Miller, R.A., Maloney, D.G., Warnke, R. & Levy, R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N. Engl. J. Med. 306, 517-522 (1982).
5. Maloney, D.G. et al. Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: The addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells. Blood 80, 1502-1510 (1992).
6. Campbell, M.J., Esserman, L., Byars, N.E., Allison, A.C. & Levy, R. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J. Immunol. 145, 1029-1036 (1990).
7. Tao, M.H. & Levy, R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362, 755-758 (1993).
8. Chen, T.T., Tao, M.H. & Levy, R. Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 153, 4775-4787 (1994).
9. George, A.J., Folkard, S.G., Hamblin, T.J. & Stevenson, F.K. Idiotypic vaccination as a treatment for a B cell lymphoma. J. Immunol. 141, 2168-2174 (1988).
10. Campbell, M.J., Esserman, L. & Levy, R. Immunotherapy of established murine B cell lymphoma: Combination of idiotype immunization and cyclophosphamide. J. Immunol. 141, 3227-3233 (1988).